CONTRAVIR PHARMACEUTICALS IN's ticker is CTRV and the CUSIP is 21234W202. A total of 20 filers reported holding CONTRAVIR PHARMACEUTICALS IN in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2018 | $27,000 | – | 96,909 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Prospera Financial Services Inc | 16,323 | $4,000 | 0.00% |
| JPMORGAN CHASE & CO | 87 | $0 | 0.00% |
| BARCLAYS PLC | 84,034 | $19,000 | 0.00% |
| ROYAL BANK OF CANADA | 7 | $0 | 0.00% |
| VANGUARD GROUP INC | 101,131 | $23,000 | 0.00% |
| LADENBURG THALMANN FINANCIAL SERVICES INC. | 3,280 | $1,000 | 0.00% |
| Capital Advisors, Ltd. LLC | 22 | $0 | 0.00% |
| UBS Group AG | 3,112 | $1,000 | 0.00% |
| Advisor Group, Inc. | 35 | $0 | 0.00% |
| BANK OF AMERICA CORP /DE/ | 336 | $0 | 0.00% |